Page 5 - Endometrial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Endometrial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Endometrial Today - Breaking & Trending Today

US FDA accepts GSK's licence application for cancer treatment Jemperli

GSK PLC on Tuesday said the US Food & Drug Administration accepted its supplemental biologics licence application for endometrial cancer treatment dostarlimab, or Jemperli, after it was granted. | June 6, 2023 ....

United Kingdom , Greg Rosenvinge , Alliance News Ltd , Oncology Center , Global Head Of Oncology Development Hesham Abdullah , Us Food Drug Administration , Alliance News , Drug Administration , Oncology Development Hesham , All Rights , Gsk Plc Stock Exchange , Press Release , As Gsk Gb00bn7swp63 ,

New treatment options being tested for endometrial cancer patients

The use of immunotherapy may prove successful for some patients, and combining this new practice with traditional treatments has shown a lot of promise. ....

Michael Robinson , National Library Of Medicine Medlineplus , Novant Health Hanover Regional Medical Center , Novant Health , National Library , Nobel Prize ,

AstraZeneca's Imfinzi shows positive results for endometrial cancer patients

AstraZeneca said results from a Phase III trial showed its Imfinzi treatment in combination with chemotherapy showed a significant improvement in patients with endometrial cancer. ....

Astrazeneca 039 S , Category All , Category Company News , Category News And Announcements , Category Sectorial Health Technology ,

AstraZeneca's Imfinzi plus Lynparza effective for endometrial cancer

AstraZeneca PLC on Friday said that its most recent trial testing Imfinzi showed that the therapy significantly improved progression-free survival in advanced endometrial cancer when added to. | May 26, 2023 ....

United Kingdom , Holly Beveridge , Susan Galbraith , Alliance News , Alliance News Ltd , All Rights , Astrazeneca Plc Stock Exchange , Press Release , Dded Azn Gb0009895292 ,